Advertisement #1
Home Tags Hepatocellular carcinoma

Tag: hepatocellular carcinoma

Adjuvant Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection of...

Editorial Team -

Activating the Immune Response Enables Liver Cancer Patient’s Immune System to...

Editorial Team -

Researchers Identify a New Subset of High-risk Pediatric Liver Cancer

Peter Hofland -

A Multi-analyte Cell-free DNA–based Blood Test for Early Detection of Hepatocellular...

Peter Hofland -

Genetic Alterations Increase the risk of Developing NASH and Fatty Liver...

Editorial Team -

Non-Invasive Screening: Innovative Technology may Halt Progression of Liver Disease to...

Douglas Dieterich, M.D. -

MilliporeSigma Awards Grant to Combined Therapeutics for Novel Therapeutic Platform

Editorial Team -
Low magnification micrograph of hepatocellular carcinoma the most common form of primary liver cancer. Features on image: End-stage cirrhosis - blue collagen (fibrosis); Mallory bodies; Loss of normal liver architecture; Nuclear atypia.

Q Biomed Continues Pre-clinical Evaluation of Uttroside-B for the Treatment of...

Editorial Team -
Blood test

FDA Grants Breakthrough Device Designation to Liquid Biopsy Liver Cancer Detection...

Peter Hofland -
Low magnification micrograph of hepatocellular carcinoma the most common form of primary liver cancer. Features on image: End-stage cirrhosis - blue collagen (fibrosis); Mallory bodies; Loss of normal liver architecture; Nuclear atypia.

Breakthrough Therapy Designation for Pembrolizumab + Lenvatinib in Hepatocellular Carcinoma

Peter Hofland -
12Page 1 of 2

LATEST NEWS

Advertisment #12
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.

X